I agree that this site is using cookies. You can find further informations here.
X
Ou, Sai-Hong Ignatius
305  results:
Search for persons X
?
1

Efficacy of Mobocertinib and Amivantamab in Patients With A..:

Ou, Sai-Hong Ignatius ; Prawitz, Thibaud ; Lin, Huamao M....
Clinical Lung Cancer.  25 (2024)  3 - p. e145-e152.e3 , 2024
Link: https://doi.org/10.1016/..
 
?
2

ALINA: Another stepping stone toward a future of LDCT lung ..:

Nagasaka, Misako ; Ly, Catherine T. ; Ou, Sai-Hong Ignatius
Med.  5 (2024)  7 - p. 649-651 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Iruplinalkib (WX-0593), the Seventh ALK Tyrosine Kinase Inh..:

Li, Molly Siu-Ching ; Ou, Sai-Hong Ignatius
Journal of Thoracic Oncology.  19 (2024)  6 - p. 855-857 , 2024
Link: https://doi.org/10.1016/..
 
?
4

MARIPOSA-2: Is the treatment worse than the disease?:

Lee, Alexandria T.M. ; Ou, Sai-Hong Ignatius
Med.  5 (2024)  6 - p. 645 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Taletrectinib for the treatment ofROS-1positive non-small c..:

Nagasaka, Misako ; Brazel, Danielle ; Ou, Sai-Hong Ignatius
Expert Opinion on Investigational Drugs.  33 (2024)  2 - p. 79-84 , 2024
Link: https://doi.org/10.1080/..
 
?
6

Chemotherapy and Osimertinib Combination Should Be the Firs..:

Chen, Lanyi Nora ; Lee, Alexandria T.M. ; Nagasaka, Misako.
Journal of Thoracic Oncology.  19 (2024)  3 - p. 380-384 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Overcoming Central β-Sheet #6 (Cβ6) ALK Mutation (L1256F), ..:

Lee, Alexandria ; Ou, Sai-Hong Ignatius
Lung Cancer: Targets and Therapy.  15 (2024)  - p. 19-27 , 2024
Link: https://doi.org/10.2147/..
 
?
8

ATTLAS, IMpower151 and ORIENT-31: Dusting off IMpower150 fo..:

Lee, Jii Bum ; Ou, Sai-Hong Ignatius
Lung Cancer: Targets and Therapy.  15 (2024)  - p. 81-85 , 2024
Link: https://doi.org/10.2147/..
 
?
9

MARIPOSA-2: Is the treatment worse than the disease?:

Lee, Alexandria T.M. ; Ou, Sai-Hong Ignatius
Med.  5 (2024)  2 - p. 115-117 , 2024
Link: https://doi.org/10.1016/..
 
?
10

A pragmatic guide for management of adverse events associat..:

Liu, Geoffrey ; Mazieres, Julien ; Stratmann, Jan...
Lung Cancer.  191 (2024)  - p. 107535 , 2024
Link: https://doi.org/10.1016/..
 
?
11

Comprehensive Review of ROS1 Tyrosine Kinase Inhibitors-Cla..:

Ou, Sai-Hong Ignatius ; Hagopian, Garo G. ; Zhang, Shannon S..
Journal of Thoracic Oncology.  19 (2024)  5 - p. 706-718 , 2024
Link: https://doi.org/10.1016/..
 
?
12

Reply to Jayaraj et al. "Clinical Validity and Conceptual I..:

Triphuridet, Natthaya ; Gao, Yanfei ; Ou, Sai-Hong Ignatius
Journal of Thoracic Oncology.  18 (2023)  10 - p. e122-e123 , 2023
Link: https://doi.org/10.1016/..
 
?
13

Overview of Drug-Drug Interactions Between Ritonavir-Booste..:

Anwar, Kaleem ; Nguyen, Lee ; Nagasaka, Misako..
JTO Clinical and Research Reports.  4 (2023)  2 - p. 100452 , 2023
Link: https://doi.org/10.1016/..
 
?
14

In Response to Dr. Steven Sorscher:

Zhang, Shannon S. ; Schrock, Alexa B. ; Nagasaka, Misako.
JTO Clinical and Research Reports.  4 (2023)  1 - p. 100453 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Lorlatinib Tolerability and Association With Clinical Outco..:

Thummalapalli, Rohit ; Choudhury, Noura J. ; Ehrich, Fiona...
JTO Clinical and Research Reports.  4 (2023)  8 - p. 100546 , 2023
Link: https://doi.org/10.1016/..
 
1-15